You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 1, January 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Alzheimer Disease
 •Cerebrovascular Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Neuropathology of Alzheimer Disease in African American and White Individuals

Consuelo H. Wilkins, MD, MS; Elizabeth A. Grant, PhD; Sarah E. Schmitt, MD; Daniel W. McKeel, MD; John C. Morris, MD

Arch Neurol. 2006;63:87-90.

Background  Data from neuropathologic studies of the frequency of Alzheimer disease (AD) among African American persons conflict as to whether the neuropathologic phenotype of AD is identical in African American and white persons.

Objectives  To examine clinical and neuropathologic phenotypes of AD in African American individuals and to compare AD and vascular burdens between African American and white persons.

Design, Setting, and Patients  Ten African American decedents who underwent brain autopsy at the Washington University Alzheimer’s Disease Research Center were matched for age, sex, and Clinical Dementia Rating with 10 white decedents between January 1, 1990, and January 1, 2000. The presence and degree of neurofibrillary tangles, senile plaques, Lewy bodies, cerebral infarcts, and cerebral amyloid angiopathy were determined.

Results  All 20 individuals had a neuropathologic diagnosis of AD. There were no group differences in the presence or number of infarcts, plaques, tangles, Lewy bodies, or amyloid angiopathy.

Conclusion  In this small sample, we found no substantive differences in the neuropathology of AD among African American and white individuals.


Author Affiliations: Departments of Internal Medicine (Dr Wilkins), Neurology (Dr Morris), Biostatistics (Dr Grant), and Pathology and Immunology (Drs McKeel and Morris), and the Alzheimer’s Disease Research Center (Drs Wilkins, Grant, McKeel, and Morris), Washington University School of Medicine, St Louis, Mo. Dr Schmitt, who was a medical student at Washington University School of Medicine when the study was conducted, is now with the Department of Neurology at the University of Pennsylvania, Philadelphia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progression of Mild Cognitive Impairment to Dementia in Clinic- vs Community-Based Cohorts
Farias et al.
Arch Neurol 2009;66:1151-1157.
ABSTRACT | FULL TEXT  

Race/ethnic differences in AD survival in US Alzheimer's Disease Centers
Mehta et al.
Neurology 2008;70:1163-1170.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.